Johnson & Johnson Completes Divestiture Of LifeScan Business To Platinum Equity

10/2/18

By Mamta Mayani, SeekingAlpha

Johnson & Johnson (NYSE:JNJ) has completed the divestiture of its LifeScan business to Platinum Equity for ~$2.1B.

JNJ will discuss this transaction during its scheduled quarterly earnings call on October 16.

Shares are down a fraction premarket.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.